Doctor Patrick Foong

Academic Program Advisor,
School of Law

Senior Lecturer,
School of Law

Biography
Contact
Publications
Projects
Teaching
Media

Biography

I am an experienced law academic. I have taught law in different countries (undergraduate and postgraduate courses including LLB & LLM) and in the last decade, in the Australasian region. I have extensive experience in designing curriculum, setting assessments and moderation. I have consistently achieved excellent teaching evaluations, and I was rated as an outstanding lecturer by Swinburne University students. I am familiar with the use of modern technologies such as Hyflex.

My research interest is in current bioethics law, including regulating stem cell research & therapy, human genome editing (CRISPR-Cas9), artificial intelligence (AI) in healthcare and research, Covid-19, personalised medicine, biobanking and other emerging biotechnologies. I publish in top law and bioethics journals, both national and international, including Asian Bioethics Review (Q1) and the Journal of Law & Medicine.Both of my postgraduate qualifications (LLM & PhD) are by research and they are in critical areas at the time. My LLM thesis was on HIV/ AIDS & Discrimination law. In my PhD thesis, I conducted analysis. I compared the Australian regulatory regime on human embryonic stem cell research and the Malaysian regime against the backdrop of the regulatory theories of Professor Roger Brownsword (Kings College London, UK) and Professor John Braithwaite (Australian National University). Their regulatory theories are of generic application and thus relevant to various types of law.

I was a visiting scholar at the University of California, Los Angeles (UCLA) law school. My project was "A Comparative Look at the US and Australian Approaches to the Regulation of Stem Cell Research and Therapy."

I am a committee member of the Legal & Regulatory Affairs (ANZ region) of International Society of Cell & Gene Therapy (ISCT). I serve as a member of the university's Low and Negligible Risk (LNR) ethics committee and, in due course, will progress to the Human Research Ethics Committee (HREC). Previously, I was the academic program advisor for the law school. I was also a member of the law school’s Research and Higher Degree Committee for several years.

This information has been contributed by Doctor Foong.

Qualifications

PhD University of Tasmania

Professional Memberships

International Society for Stem Cell Research (ISSCR) (2012 - 2019)

Organisational Unit (School / Division)

School of Law
School of Law

Contact

Email:	P.Foong@westernsydney.edu.au
Phone:	(02) 9685 9217
Mobile:
Location:	EK.G.37 Parramatta

PLEASE NOTE: obtaining information from this Directory must be for the legitimate purposes of doing business with and within Western Sydney University, and must not be used for unsolicited bulk e-mailing (spamming) or similar purposes.

Teaching

Previous Teaching Areas

200011 Contracts, 2020
200295 Bioethics, 2019
200813 Civil Procedure and Arbitration, 2019
200957 Bioethics in Perspective, 2019

Publications

Journal Articles

Foong, P. (2023), 'Unproven stem cell industry in the U.S. : regulatory challenges and enforcement issues', Biotechnology Law Report, vol 42, no 4 .
Hashimi, M. and Foong, P. (2022), 'The drawing-up of laws on research involving human embryos in Australia : lack of an Islamic voice', Biotechnology Law Report, vol 41, no 1 , pp 30 - 38.
Foong, C. and Borsellino, G. (2022), 'Regulation of clinical trials and pandemic research : upholding ethical standards during a COVID-19 crisis', Biotechnology Law Report, vol 41, no 3 , pp 138 - 153.
Mangiapane, M. and Foong, P. (2022), 'How Australia's policymakers can ethically approach human germline genome editing technology', Journal of Law and Medicine, vol 29, no 3 , pp 740 - 759.
Borsellino, G., Foong, C. and Allan, S. (2021), 'The regulation and governance of clinical trials : past and present considerations to ensure ethical treatment of human participants', Journal of Law and Medicine, vol 28 , pp 421 - 438.
McKenzie, A. and Foong, C. (2021), 'Crispr-Cas9: The need for law reform in Australia', Eubios Journal of Asian and International Bioethics, vol 31, no 7 , pp 366 - 369.
Foong, C. (2020), 'Regulating unproven stem cell interventions : how effective are the ISSCR guidelines?', Biotechnology Law Report, vol 39, no 3 , pp 196 - 203.
Foong, C. (2019), 'Regulating human genome editing in Australia : overdue legislative review', Biotechnology Law Report, vol 38, no 1 .
Foong, C. (2019), 'Ownership issues in autologous stem cell therapies', Eubios Journal of Asian and International Bioethics, vol 29, no 6 , pp 186 - 191.
Foong, C. (2018), 'Stem cell tourism : addressing the challenge of regulatory cosmopolitanism', Eubios Journal of Asian and International Bioethics, vol 28, no 4 , pp 118 - 127.
Foong, C. (2018), 'Stemming the tide of unproven autologous stem cell therapies in Australia', University of New South Wales Law Journal Forum, .
Foong, C. (2017), 'Is human embryonic stem cell (HESC) research still necessary today?', Asian Bioethics Review, vol 9, no 1-2 , pp 33 - 44.
Foong, C. (2016), 'The regulatory regime for the use of embryos in research : Braithwaite's theory of responsive regulation', Eubios Journal of Asian and International Bioethics, vol 26, no 5 , pp 200 - 206.
Foong, C. (2016), 'Regulating human embryonic stem cell (HESC) research in Australia : Brownsword's regulatory challenges', Curtin Law and Taxation Review, vol 3 , pp 131 - 170.
Foong, C. (2014), 'Addressing exploitation of women in therapeutic cloning/somatic cell nuclear transfer (SCNT) research through strict legal oversight in Australia', Asian Bioethics Review, vol 6, no 4 , pp 359 - 370.
Foong, C. (2012), 'The need to pay egg donors for use in therapeutic cloning/Somatic Cell Nuclear Transfer (SCNT) research', Legal Issues in Business, vol 14 , pp 3 - 8.
Foong, C. (2012), 'The regulatory regime for human embryonic stem cell (HESC) research in Malaysia : a critique', Journal Undang-Udang dan Masyarakat: Malaysian Journal of Law and Society, vol 16 , pp 55 - 68.
Foong, C. (2011), 'Human embryonic stem cell (HESC) research in Malaysia : multi-faith perspectives', Asian Bioethics Review, vol 3, no 3 , pp 182 - 206.

My PhD topic was in the regulation of the controversial embryonic stem cell research. My current research interest is in the ethics and law of emerging biotechnologies eg organoid technology, human genome editing (eg CRISPR-Cas9), sheefs and others.

I publish in leading journals, national (eg UNSW Law Journal and Journal of law & Medicine) and international (eg Asian Bioethics Review, Tier 1 for Philosophy).

Each year, I present at the annual conference of International Society for Stem Cell Research (ISSCR), the largest stem cell organisation in the world as well as other conferences (national and international) and other conferences.

I have also contributed to The Conversation and they have been captured by the media (see 'Media'). I was interviewed by various media outlets, including The Guardian.

My research should be useful to scientists, doctors, patients and their advocates/ carers, regulators, policy-makers, researchers and all concerned citizens, national as well as international.

I was a member of the School of Law’s Research and Higher Degree Committee.